Loading...

enVVeno Medical Corporation

NVNOWNASDAQ
Healthcare
Medical - Devices
$0.006
$-0.00(-32.98%)

enVVeno Medical Corporation NVNOW Peers

See (NVNOW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
NVNOW$0.01-32.98%74M-0.00-$1.90N/A
ABT$134.44+0.25%233.9B17.48$7.69+1.70%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$104.32+0.67%154.3B76.15$1.37N/A
SYK$395.28+0.89%151.1B53.49$7.39+0.84%
MDT$88.39+0.12%113.3B24.48$3.61+3.18%
EW$76.79-0.30%45B31.73$2.42N/A
DXCM$82.93-0.78%32.5B62.35$1.33N/A
STE$237.55-0.29%23.4B38.56$6.16+0.96%
PHG$24.17-1.43%22.4B80.57$0.30+3.67%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

NVNOW vs ABT Comparison

NVNOW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NVNOW stands at 74M. In comparison, ABT has a market cap of 233.9B. Regarding current trading prices, NVNOW is priced at $0.01, while ABT trades at $134.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NVNOW currently has a P/E ratio of -0.00, whereas ABT's P/E ratio is 17.48. In terms of profitability, NVNOW's ROE is -0.51%, compared to ABT's ROE of +0.31%. Regarding short-term risk, NVNOW is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for NVNOW.

Stock Price Comparison

Loading...

Frequently Asked Questions

;